Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499354 · ClinicalTrials.gov registry record · Phase 2
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
A Phase 2 study, sponsored by Auerbach Hematology Oncology Associates P C.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT02499354 is a Phase 2 study that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 100 participants.
The verdict
NCT02499354, a Phase 2 study, has completed, sponsored by Auerbach Hematology Oncology Associates P C.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the relative effect size of standard IV and oral iron treatment of RLS with Iron deficiency anemia (IDA) and to determine the time course of treatment response.
Interventions
- DRUG Ferrous sulfate
- DRUG Ferumoxytol intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-08 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02499354
The ClinicalTrials.gov registry entry for NCT02499354 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auerbach Hematology Oncology Associates P C, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous sulfate is the first listed.
NCT02499354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02499354 about?
NCT02499354 is a clinical study titled "Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)". The purpose of the study is to determine the relative effect size of standard IV and oral iron treatment of RLS with Iron deficiency anemia (IDA) and to determine the time course of treatment response.
What is the current status of trial NCT02499354?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2014-08. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT02499354?
The interventions under investigation include: Ferrous sulfate (DRUG), Ferumoxytol intravenous (DRUG).
Who is sponsoring clinical trial NCT02499354?
This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.